Baylon, Junie B.
HRN: 28-29-08 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/16/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/16/2025
12/22/2025
IV
500MG
Q8
FOR OR
Checking Final Appropriateness
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominalProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes